William E. Rote insider trades

Open-market stock purchases and sales by William E. Rote, Chief Research Officer at Travere Therapeutics, Inc, from SEC Form 4 filings since Feb 13, 2017.

Recent trades

DateStockTradeValue
Sep 16, 2026TVTX Travere Therapeutics, IncSold$4.1M
Sep 16, 2026TVTX Travere Therapeutics, IncSold$3M
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncSold$4M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$1.8M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$191K
Sep 15, 2026TVTX Travere Therapeutics, IncSold$17.6K
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 6, 2026TVTX Travere Therapeutics, IncSold$121K
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 22, 2026TVTX Travere Therapeutics, IncSold$356K
Apr 13, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Feb 3, 2026TVTX Travere Therapeutics, IncSold$409K
Jan 31, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Jan 31, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Dec 24, 2025TVTX Travere Therapeutics, IncSold$2.4M
Dec 24, 2025TVTX Travere Therapeutics, IncBought (not open market)—

Companies traded

  • TVTX Travere Therapeutics, Inc: 38 sales, last Sep 16, 2026
  • RTRX Travere Therapeutics, Inc: 17 sales, last Nov 16, 2020

Get free alerts when William E. Rote files a new trade →